FDA authorizes clinical trial of United Therapeutics’ Treprostinil-Iloprost SMI
The FDA authorized a clinical trial of United Therapeutics’ Treprostinil-Iloprost SMI.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The FDA authorized a clinical trial of United Therapeutics’ Treprostinil-Iloprost SMI.